Newsfile Corp. is a press release service for companies of all sizes. With a distribution of over 6,000 media and financial databases, Newsfile delivers press releases to a global audience.
BUSINESS ACCOUNT
Sign up for a business account to:
-
Access reports individually or via Subscription
-
Receive monthly invoices with payment via CSA or hard dollars
Get access to other exclusive features
-
Analyst access
-
Free Trial Subscriptions
-
Team account with shared subscriptions
-
Advanced analytics to track research consumption and performance
Cardiol Therapeutics Announces Closing of Bought Deal Financing and Fu...
Toronto, Ontario--(Newsfile Corp. - January 23, 2026) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease, today announced that it has closed its previously announced private placement of units (the "Units") of the Company (the "Offering"), including the full exercise of the over-allotment option. Canaccord Genuity Corp. (the "Underwriter") acted as sole underwriter and sole bookrunner for the Offering. Pursuant to the Offer...
Thiogenesis Presents Phase 2 (EU) MELAS Data at Mitocon 2026
Highlighting Optimized Once-Daily Weight-Based Dosing and Clinically Meaningful Fatigue ImprovementSan Diego, California--(Newsfile Corp. - January 23, 2026) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ("Thiogenesis" or the "Company"), a clinical-stage biotechnology company developing next-generation thiol-based prodrugs for rare mitochondrial and pediatric diseases, today announced the presentation of interim data from its Phase 2 (EU) clinical study of TTI-0102 in patients with Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes (MELAS) at Mitocon 2026...
Kenorland Minerals Grants Stock Options
Vancouver, British Columbia--(Newsfile Corp. - January 23, 2026) - Kenorland Minerals Ltd. (TSXV: KLD) (OTCQX: KLDCF) (FSE: 3WQ0) ("Kenorland" or the "Company") announces that it has granted stock options (the "Options") to its directors, officers, employees and consultants to acquire a total of 4,080,000 common shares of the Company at an exercise price of $3.31 per share for a period of five years. The Options vest one-third immediately, followed by one-third every year thereafter.About Kenorland MineralsKenorland Minerals Ltd. (TSXV: KLD) is a well-financed mineral exploration company focus...
Romios Announces Completion of NI 43-101 Technical Report for the 100%...
Toronto, Ontario--(Newsfile Corp. - January 22, 2026) - Romios Gold Resources Inc. (TSXV: RG) (OTCID: RMIOF) (FSE: D4R) ("Romios" or the "Company") is pleased to announce the completion of a National Instrument 43-101 ("NI 43-101") technical report dated January 20th, 2026, entitled "Technical Report on the Trek Property" (the "Technical Report") in respect of its 100% owned Trek Property in the Golden Triangle area of British Columbia. The Technical Report was authored by independent Qualified Person Linda Dandy, P.Geo., and non-independent Qualified Person John L. Biczok, P.Geo., the Vice Pr...
Tudor Gold Announces Updated Mineral Resource Estimate for Treaty Cree...
Vancouver, British Columbia--(Newsfile Corp. - January 22, 2026) - Tudor Gold Corp. (TSXV: TUD) (FSE: H56) (the "Company" or "Tudor") is pleased to report an updated Mineral Resource estimate (the "2026 MRE") with higher-grade sensitivities for the Goldstorm Deposit at its flagship Treaty Creek Project located in the Golden Triangle, British Columbia. The 2026 MRE was prepared by Garth Kirkham, P.Geo. of Kirkham Geosystems Ltd. ("KGL") in accordance with National Instrument 43-101, Standards of Disclosure for Mineral Projects ("NI 43-101").Treaty Creek 2026 MRE Highlights2026 MRE at a net sme...
